Breaking News Instant updates and real-time market news.

FTSV

Forty Seven

$35.98 /

-0.49 (-1.34%)

08:15
01/10/20
01/10
08:15
01/10/20
08:15

Forty Seven CEO expects 2020 to be year of 'notable progress' across portfolio

Forty Seven outlined its strategic plan and expected milestones for 2020. "Our vision is to deliver groundbreaking therapies to patients by harnessing the potential of the innate immune system in the fight against disease," said Mark McCamish, M.D., Ph.D., President and CEO of Forty Seven. "As we enter the new year, we are executing against this strategy with full force. Our potential-registration enabling programs for magrolimab in MDS and DLBCL are underway, and we are pleased to have recently received FDA Orphan Drug designation for magrolimab in MDS. In parallel, we are preparing to advance FSI-174 and FSI-189 into the clinic, where we believe we can leverage our deep understanding of the CD47/SIRPalpha pathway to engage previously unexploited phagocytic pathways. Following our successful follow-on offering in December 2019, we are well financed, with sufficient resources to advance our pipeline through key milestones, including the potential submission of our first biologics license application for magrolimab, while scaling our CMC activities to support future product launches. We expect 2020 to be a year of notable progress across our portfolio, as we read out data for each of our magrolimab programs and accelerate ongoing efforts to offer magrolimab to genomically-defined patient populations, like TP53-mutant AML, where we believe our approach can offer targeted benefit. We will simultaneously progress our earlier-stage assets, FSI-174 and FSI-189, in hopes of delivering on the full potential of macrophage biology for people living with cancer and other serious diseases."

FTSV Forty Seven
$35.98 /

-0.49 (-1.34%)

01/07/20 Roth Capital
Forty Seven price target raised to $55 from $35 at Roth Capital
12/11/19 Guggenheim
Forty Seven price target to $48 from $20 at Guggenheim
12/10/19 Roth Capital
Forty Seven price target raised to $35 from $28 at Roth Capital
12/10/19 Morgan Stanley
Forty Seven price target raised to $45 from $17 at Morgan Stanley

TODAY'S FREE FLY STORIES

On The Fly
Fly Intel: Wall Street's top stories at midday » 12:28
02/20/20
02/20
12:28
02/20/20
12:28
MS

Morgan Stanley

$54.19 /

-2.12 (-3.76%)

, ETFC

E-Trade

$55.82 /

+10.88 (+24.21%)

, LB

L Brands

$24.44 /

+0.445 (+1.85%)

, IOTS

Adesto Technologies

$12.36 /

+4.37 (+54.69%)

, DLGNF

Dialog Semiconductor

$0.00 /

+ (+0.00%)

, VIAC

ViacomCBS

$29.80 /

-5.89 (-16.50%)

, SIX

Six Flags

$31.11 /

-6.9 (-18.15%)

, DPZ

Domino's Pizza

$367.08 /

+69.62 (+23.40%)

, STMP

Stamps.com

$151.07 /

+55.68 (+58.37%)

, CYH

Community Health

$6.72 /

+1.92 (+40.00%)

, TEVA

Teva

$13.15 /

-0.31 (-2.30%)

, TVTY

Tivity Health

$12.71 /

-10.2 (-44.52%)

, AAN

Aaron's

$45.10 /

-11.035 (-19.66%)

Stocks are down at midday…

Open Full Text

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Ally Financial call volume above normal and directionally bullish » 12:25
02/20/20
02/20
12:25
02/20/20
12:25
ALLY

Ally Financial

$28.50 /

+0.155 (+0.55%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Apple iPhone sales in China may decline 40%to 50%, Global Times says » 12:24
02/20/20
02/20
12:24
02/20/20
12:24
AAPL

Apple

$319.20 /

-4.44 (-1.37%)

According to an earlier…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Tandem Diabetes announces 'positive data' presented at ATTD meeting » 12:23
02/20/20
02/20
12:23
02/20/20
12:23
TNDM

TNDM

/

+

Tandem Diabetes Care…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Tesla most improved car brand in CR rankings, jumps to 11 from 18 » 12:22
02/20/20
02/20
12:22
02/20/20
12:22
TSLA

Tesla

$883.66 /

-33.35 (-3.64%)

, POAHY

Porsche

$0.00 /

+ (+0.00%)

, TM

Toyota

$138.67 /

+0.79 (+0.57%)

, HMC

Honda

$27.24 /

+0.15 (+0.55%)

Tesla (TSLA) was the…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Consumer Reports names Tesla Model 3 top electric car of 2020 » 12:20
02/20/20
02/20
12:20
02/20/20
12:20
TSLA

Tesla

$882.84 /

-34.17 (-3.73%)

, F

Ford

$8.01 /

+0.01 (+0.13%)

, GM

General Motors

$34.91 /

+ (+0.00%)

, HMC

Honda

$27.24 /

+0.15 (+0.55%)

, NSANY

Nissan

$0.00 /

+ (+0.00%)

, TM

Toyota

$138.67 /

+0.79 (+0.57%)

, DDAIF

Daimler AG

$0.00 /

+ (+0.00%)

, FCAU

Fiat Chrysler

$13.27 /

+0.055 (+0.42%)

, VWAGY

Volkswagen

$0.00 /

+ (+0.00%)

Consumer Reports issued…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

General news
Wall Street hit an air pocket and the indexed dropped precipitously » 12:20
02/20/20
02/20
12:20
02/20/20
12:20

Wall Street hit an air…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Technical Analysis
NASDAQ market internals summary » 12:17
02/20/20
02/20
12:17
02/20/20
12:17
$NSD

NASDAQ Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Technical Analysis
NYSE market internals summary » 12:16
02/20/20
02/20
12:16
02/20/20
12:16
$NYE

NYSE Market Internals

$0.00 /

+ (+0.00%)

Volume is above average…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

Options
Weibo put volume heavy and directionally bearish » 12:15
02/20/20
02/20
12:15
02/20/20
12:15
WB

Weibo

$43.36 /

+0.44 (+1.03%)

Bearish flow noted in…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Engie approaches Ameresco over acquisition interest, Reuters reports » 12:14
02/20/20
02/20
12:14
02/20/20
12:14
ENGIY

Engie SA

$0.00 /

+ (+0.00%)

, AMRC

Ameresco

$25.74 /

+2.94 (+12.89%)

France's Engie…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Microsoft to bring Defender antivirus software to Android, iOS » 12:12
02/20/20
02/20
12:12
02/20/20
12:12
MSFT

Microsoft

$183.33 /

-3.98 (-2.12%)

, GOOG

Alphabet

$1,517.57 /

-9.33 (-0.61%)

, GOOGL

Alphabet Class A

$1,514.20 /

-10.81 (-0.71%)

, AAPL

Apple

$319.90 /

-3.74 (-1.16%)

Microsoft (MSFT)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
WarnerMedia reaches deal to bring HBO Max to YouTube TV, CNN Business reports » 12:09
02/20/20
02/20
12:09
02/20/20
12:09
T

AT&T

$38.41 /

-0.03 (-0.08%)

, GOOG

Alphabet

$1,517.30 /

-9.6 (-0.63%)

, GOOGL

Alphabet Class A

$1,515.16 /

-9.85 (-0.65%)

AT&T's (T)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Periodicals
Schrodinger jumps after Citron likens to Tesla, puts $80 target on shares » 12:09
02/20/20
02/20
12:09
02/20/20
12:09
SDGR

Schrodinger

$34.74 /

-0.895 (-2.51%)

, TSLA

Tesla

$880.96 /

-36.05 (-3.93%)

Andrew Left's Citron…

Andrew Left's Citron Research calls Schrodinger (SDGR) the most important initial public offering in the past five years and says the similarities between the company and Tesla (TSLA) are "too obvious to ignore." Both Tesla and Schrodinger were founded on the premise of using technology and software to solve problems of humanity, Citron wrote in a new report posted on its website. "In the case of Tesla, carbon emissions and Schrodinger, expediting the drug development process through software that advances chemistry beyond limits ever imagined," the firm contends. "With the massive premiums being paid for pharma companies with disruptive drug assets, Citron expects Wall Street to quickly re-rate Schrodinger shares much higher," the firm best known for short selling concludes. Citron placed an $80 price target on Schrodinger shares. The stock in midday trading is up 7%, or $2.45, to $38.17. Reference Link

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
L Brands downgraded to Hold from Buy at Odeon Capital » 12:06
02/20/20
02/20
12:06
02/20/20
12:06
LB

L Brands

$24.37 /

+0.375 (+1.56%)

Odeon Capital analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Downgrade
Autohome downgraded to Underperform from Neutral at CICC » 12:05
02/20/20
02/20
12:05
02/20/20
12:05
ATHM

Autohome

$84.30 /

-4.35 (-4.91%)

CICC downgraded Autohome…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Options
Jumia Technologies call volume above normal and directionally bullish » 12:05
02/20/20
02/20
12:05
02/20/20
12:05
JMIA

Jumia Technologies

$6.21 /

+0.415 (+7.16%)

Bullish option flow…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Schrodinger jumps 6% to $37.78 after Citron puts $80 target on shares  12:03
02/20/20
02/20
12:03
02/20/20
12:03
SDGR

Schrodinger

$34.46 /

-1.17 (-3.28%)

 
Periodicals
Citron Research puts $80 price target on Schrodinger  12:03
02/20/20
02/20
12:03
02/20/20
12:03
SDGR

Schrodinger

$34.46 /

-1.17 (-3.28%)

 
Recommendations
Pacira price target raised to $60 from $54 at Piper Sandler » 12:02
02/20/20
02/20
12:02
02/20/20
12:02
PCRX

Pacira

$49.47 /

-1.23 (-2.43%)

, HRTX

Heron Therapeutics

$20.23 /

-1.43 (-6.60%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Six Flags falls -17.9% » 12:00
02/20/20
02/20
12:00
02/20/20
12:00
SIX

Six Flags

$31.20 /

-6.81 (-17.92%)

Six Flags is down -17.9%,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Aaron's falls -19.5% » 12:00
02/20/20
02/20
12:00
02/20/20
12:00
AAN

Aaron's

$44.88 /

-11.25 (-20.04%)

Aaron's is down…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Mednax falls -22.4% » 12:00
02/20/20
02/20
12:00
02/20/20
12:00
MD

Mednax

$20.99 /

-5.66 (-21.24%)

Mednax is down -22.4%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Nautilus rises 21.0% » 12:00
02/20/20
02/20
12:00
02/20/20
12:00
NLS

Nautilus

$3.52 /

+0.58 (+19.73%)

Nautilus is up 21.0%, or…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Hot Stocks
Domino's Pizza rises 23.1% » 12:00
02/20/20
02/20
12:00
02/20/20
12:00
DPZ

Domino's Pizza

$366.81 /

+69.345 (+23.31%)

Domino's Pizza is up…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.